| Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19 L Naymagon, N Zubizarreta, J Feld, M van Gerwen, M Alsen, S Thibaud, ... Thrombosis research 196, 99-105, 2020 | 156 | 2020 |
| Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study D Tremblay, M Van Gerwen, M Alsen, S Thibaud, A Kessler, S Venugopal, ... Blood, The Journal of the American Society of Hematology 136 (1), 144-147, 2020 | 150 | 2020 |
| Cancer care disparities during the COVID-19 pandemic: COVID-19 and cancer outcomes study AL Schmidt, Z Bakouny, S Bhalla, JA Steinharter, DA Tremblay, MM Awad, ... Cancer cell 38 (6), 769-770, 2020 | 63 | 2020 |
| Immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction: adjunctive role of the ALBI grade DJ Pinato, T Kaneko, A Saeed, T Pressiani, A Kaseb, Y Wang, D Szafron, ... Cancers 12 (7), 1862, 2020 | 57 | 2020 |
| Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation A Sacher, P LoRusso, MR Patel, WH Miller Jr, E Garralda, MD Forster, ... New England Journal of Medicine 389 (8), 710-721, 2023 | 54 | 2023 |
| Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study P Fessas, A Kaseb, Y Wang, A Saeed, D Szafron, T Jun, S Dharmapuri, ... Journal for immunotherapy of cancer 8 (2), 2020 | 54 | 2020 |
| Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: evidence from an FDA pooled analysis of landmark clinical trials with validation … DJ Pinato, TU Marron, PS Mishra-Kalyani, Y Gong, G Wei, D Szafron, ... European Journal of Cancer 157, 140-152, 2021 | 52 | 2021 |
| The systemic inflammatory response identifies patients with adverse clinical outcome from immunotherapy in hepatocellular carcinoma A Muhammed, CAM Fulgenzi, S Dharmapuri, M Pinter, L Balcar, ... Cancers 14 (1), 186, 2021 | 47 | 2021 |
| Convalescent plasma for the treatment of severe COVID‐19 infection in cancer patients D Tremblay, C Seah, T Schneider, S Bhalla, J Feld, L Naymagon, B Wang, ... Cancer medicine 9 (22), 8571-8578, 2020 | 46 | 2020 |
| HBV/HIV coinfection is associated with poorer outcomes in hospitalized patients with HBV or HIV R Rajbhandari, T Jun, H Khalili, RT Chung, AN Ananthakrishnan Journal of viral hepatitis 23 (10), 820-829, 2016 | 46 | 2016 |
| Early antibiotic exposure is not detrimental to therapeutic effect from immunotherapy in hepatocellular carcinoma P Fessas, M Naeem, M Pinter, TU Marron, D Szafron, L Balcar, A Saeed, ... Liver Cancer 10 (6), 583-592, 2021 | 37 | 2021 |
| Gene networks that compensate for crosstalk with crosstalk IE Müller, JR Rubens, T Jun, D Graham, R Xavier, TK Lu Nature Communications 10 (1), 4028, 2019 | 37 | 2019 |
| Analysis of sex-specific risk factors and clinical outcomes in COVID-19 T Jun, S Nirenberg, T Weinberger, N Sharma, E Pujadas, ... Communications Medicine 1 (1), 3, 2021 | 35 | 2021 |
| A review of longitudinal clinical programs in US medical schools G Gheihman, T Jun, GJ Young, D Liebman, K Sharma, E Brandes, B Ogur, ... Medical Education Online 23 (1), 1444900, 2018 | 34 | 2018 |
| Mac‐2 binding protein glycosylation isomer as a hepatocellular carcinoma marker in patients with chronic hepatitis B or C infection T Jun, YC Hsu, S Ogawa, YT Huang, ML Yeh, CH Tseng, CF Huang, ... Hepatology communications 3 (4), 493-503, 2019 | 30 | 2019 |
| Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti‐viral therapy in patients with chronic hepatitis B YC Hsu, T Jun, YT Huang, ML Yeh, CL Lee, S Ogawa, SH Cho, JT Lin, ... Alimentary pharmacology & therapeutics 48 (10), 1128-1137, 2018 | 30 | 2018 |
| More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma TW Jun, ML Yeh, JD Yang, VL Chen, P Nguyen, NH Giama, CF Huang, ... Liver International 38 (5), 895-902, 2018 | 29 | 2018 |
| Genomic and molecular features distinguish young adult cancer from later-onset cancer W Lee, Z Wang, M Saffern, T Jun, K Huang Cell reports 37 (7), 2021 | 26 | 2021 |
| Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy DJ Pinato, A Kaseb, Y Wang, A Saeed, D Szafron, T Jun, S Dharmapuri, ... Journal for immunotherapy of cancer 8 (2), 2020 | 26 | 2020 |
| PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer VS Koshkin, VG Patel, A Ali, MA Bilen, D Ravindranathan, JJ Park, ... Prostate cancer and prostatic diseases 25 (3), 388-396, 2022 | 22 | 2022 |
